Lutetium-177-PSMA-617 in oligo-metastatic hormone sensitive prostate cancer (Bullseye)

B. Prive; C. H. J. Muselaers; D. Meijer; W. A. Van Gemert; B. Timmermans; M. J. R. Janssen; M. A. Jonker; M. de Groot; I. M. van Oort; N. Mehra; W. R. Gerritsen; E. Alevroudis; A. Vrachimis; J. A. Gietema; M. Gotthardt; A. N. Vis; I. J. de Jong; A. J. Witjes; W. Noordzij; D. E. Oprea-Lager; J. Nagarajah

Lutetium-177-PSMA-617 in oligo-metastatic hormone sensitive prostate cancer (Bullseye)

B. Prive
, C. H. J. Muselaers
, D. Meijer
, W. A. Van Gemert
, B. Timmermans
, M. J. R. Janssen
, M. A. Jonker
, M. de Groot
, I. M. van Oort
, N. Mehra
, W. R. Gerritsen
, E. Alevroudis
, A. Vrachimis
, J. A. Gietema
, M. Gotthardt
, A. N. Vis
, I. J. de Jong
, A. J. Witjes
, W. Noordzij
, D. E. Oprea-Lager

J. Nagarajah

Radiotherapy

Radboud University Nijmegen
University of Groningen
University of Amsterdam

Research output: Contribution to journal › Meeting Abstract › Academic › peer-review

Original language	English
Pages (from-to)	S154-S154
Number of pages	1
Journal	European Journal of Nuclear Medicine and Molecular Imaging
Volume	50
Issue number	SUPPL 1
Publication status	Published - Sept 2023
Event	Annual Congress of the European-Association-of-Nuclear-Medicine (EANM) - Vienna, Austria Duration: 9 Sept 2023 → 13 Sept 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

https://link.springer.com/journal/259/volumes-and-issues/50-1/supplement

Cite this

Prive, B., Muselaers, C. H. J., Meijer, D., Van Gemert, W. A., Timmermans, B., Janssen, M. J. R., Jonker, M. A., de Groot, M., van Oort, I. M., Mehra, N., Gerritsen, W. R., Alevroudis, E., Vrachimis, A., Gietema, J. A., Gotthardt, M., Vis, A. N., de Jong, I. J., Witjes, A. J., Noordzij, W., ... Nagarajah, J. (2023). Lutetium-177-PSMA-617 in oligo-metastatic hormone sensitive prostate cancer (Bullseye). European Journal of Nuclear Medicine and Molecular Imaging, 50(SUPPL 1), S154-S154. https://link.springer.com/journal/259/volumes-and-issues/50-1/supplement

@article{4b4ebc3dd5f5487bbddce192435f8932,

title = "Lutetium-177-PSMA-617 in oligo-metastatic hormone sensitive prostate cancer (Bullseye)",

author = "B. Prive and Muselaers, \{C. H. J.\} and D. Meijer and \{Van Gemert\}, \{W. A.\} and B. Timmermans and Janssen, \{M. J. R.\} and Jonker, \{M. A.\} and \{de Groot\}, M. and \{van Oort\}, \{I. M.\} and N. Mehra and Gerritsen, \{W. R.\} and E. Alevroudis and A. Vrachimis and Gietema, \{J. A.\} and M. Gotthardt and Vis, \{A. N.\} and \{de Jong\}, \{I. J.\} and Witjes, \{A. J.\} and W. Noordzij and Oprea-Lager, \{D. E.\} and J. Nagarajah",

year = "2023",

month = sep,

language = "English",

volume = "50",

pages = "S154--S154",

number = "SUPPL 1",

note = "Annual Congress of the European-Association-of-Nuclear-Medicine (EANM) ; Conference date: 09-09-2023 Through 13-09-2023",

}

Prive, B, Muselaers, CHJ, Meijer, D, Van Gemert, WA, Timmermans, B, Janssen, MJR, Jonker, MA, de Groot, M, van Oort, IM, Mehra, N, Gerritsen, WR, Alevroudis, E, Vrachimis, A, Gietema, JA, Gotthardt, M, Vis, AN, de Jong, IJ, Witjes, AJ, Noordzij, W, Oprea-Lager, DE & Nagarajah, J 2023, 'Lutetium-177-PSMA-617 in oligo-metastatic hormone sensitive prostate cancer (Bullseye)', European Journal of Nuclear Medicine and Molecular Imaging, vol. 50, no. SUPPL 1, pp. S154-S154. <https://link.springer.com/journal/259/volumes-and-issues/50-1/supplement>

TY - JOUR

T1 - Lutetium-177-PSMA-617 in oligo-metastatic hormone sensitive prostate cancer (Bullseye)

AU - Prive, B.

AU - Muselaers, C. H. J.

AU - Meijer, D.

AU - Van Gemert, W. A.

AU - Timmermans, B.

AU - Janssen, M. J. R.

AU - Jonker, M. A.

AU - de Groot, M.

AU - van Oort, I. M.

AU - Mehra, N.

AU - Gerritsen, W. R.

AU - Alevroudis, E.

AU - Vrachimis, A.

AU - Gietema, J. A.

AU - Gotthardt, M.

AU - Vis, A. N.

AU - de Jong, I. J.

AU - Witjes, A. J.

AU - Noordzij, W.

AU - Oprea-Lager, D. E.

AU - Nagarajah, J.

PY - 2023/9

Y1 - 2023/9

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=eur_pure&SrcAuth=WosAPI&KeyUT=WOS:001084059700330&DestLinkType=FullRecord&DestApp=WOS_CPL

M3 - Meeting Abstract

SN - 1619-7070

VL - 50

SP - S154-S154

JO - European Journal of Nuclear Medicine and Molecular Imaging

JF - European Journal of Nuclear Medicine and Molecular Imaging

IS - SUPPL 1

T2 - Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)

Y2 - 9 September 2023 through 13 September 2023

ER -

Lutetium-177-PSMA-617 in oligo-metastatic hormone sensitive prostate cancer (Bullseye)

UN SDGs

Access to Document

Other files and links

Cite this